Research article · 2011
Conference abstractPublished 16 Apr 2018
The response to the administration of insulin is personalized - genetic determined
University of Oradea, Romania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The main objective of this presentation is to attract attention that the response to the administration of insulin is personalized âÂ?Â? genetic determined. One of the most difficult problems in the medical practice is to establish the required of the insulin at a patient who need insulin therapy, indifferent that this is a young patient with type 1 insulin-depended diabetes mellitus or a patient with type 2 diabetes mellitus who in one moment need insulin administration âÂ?Â? insulin necessitate. Theoretically appear simple in the first instance, because we have a standard protocol to calculate the necessary of insulin like 0,3 UI insulin/kg body and after that to devised the doses depend what type of scheme we want to start: an intensification scheme in four or three administrations per days fast insulin and one Lantus insulin at 21 a clock - more physiologically or an conventional scheme in two prizes of NPH insulin in the morning and afternoon and the doses depend the body mass of a person. But, practical experience showed that after scheme of insulin was started, the patient must to be very carefully monitories and supervise to adjust the doses of insulin in compliance with the glycemic profile of the patient, We can’t appreciate exactly how much follow to decrease the level of glycemia after was administrated the same quantity (units of insulin) at the same patient with the same body mass and the same level of glycemia. The response is different, but we expect to be the same. I believe with strong opinion that only in moment when we will know the genome of the patient (the genetic profile), to can calculate the genetic necessary of insulin of every person we can establish the truth and will be avoid so many dangerous hypoglycemic accidents in present. The future will be to can determine the genetic necessary of the insulin administration of every person, after we will know the genome of the person. With this method we will have possibility to can avoid many dangerous hypoglycemic accidents happened in present.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Sep 2024
The Intersection of Genetics and Drug Response: Advancing Personalized Medicine
Article · 29 Apr 2024
Assessment of Genetic Variants Associated with Drug Metabolism and Response: Pharmacogenomic Insights into Personalized Medicine Strategies
Article · 31 Dec 2025
Genetic Determinants of Individual Drug Response
Review article · 21 Jun 2013
PHARMACOGENETICS: GENETICALLY DETERMINED VARIATIONS IN DRUG RESPONSE
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Manuela Stoicescu”

